Vapotherm Inc (NYSE:VAPO) Director Elizabeth H. Weatherman acquired 8,382 shares of Vapotherm stock in a transaction on Friday, September 6th. The stock was purchased at an average price of $11.38 per share, with a total value of $95,387.16.
Vapotherm stock traded down $1.71 on Monday, hitting $9.56. The company’s stock had a trading volume of 4,905 shares, compared to its average volume of 208,052. The firm has a market cap of $194.59 million and a P/E ratio of -0.68. The company has a quick ratio of 4.34, a current ratio of 5.22 and a debt-to-equity ratio of 1.42. The company has a fifty day moving average price of $14.63 and a 200-day moving average price of $17.92. Vapotherm Inc has a one year low of $9.31 and a one year high of $24.63.
Vapotherm (NYSE:VAPO) last announced its quarterly earnings data on Monday, July 29th. The company reported ($0.76) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.81) by $0.05. The business had revenue of $11.99 million during the quarter, compared to analyst estimates of $11.90 million. Analysts anticipate that Vapotherm Inc will post -3.07 EPS for the current year.
Separately, Zacks Investment Research upgraded Vapotherm from a “hold” rating to a “buy” rating and set a $18.00 price objective on the stock in a research report on Friday, August 2nd. Five investment analysts have rated the stock with a buy rating, Vapotherm has an average rating of “Buy” and an average price target of $23.67.
Vapotherm Company Profile
Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.
Featured Story: Are FAANG stocks a good investment?
Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.